[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Daiichi Sankyo Company Limited

Daiichi Sankyo announces positive trial results for its oncology pipeline, but faces ongoing pricing and market access challenges for key drugs like Enhertu.

About Daiichi Sankyo Company Limited

Daiichi Sankyo Company Limited is a global pharmaceutical company focused on oncology.

Insights

Price: $

Price Line Chart
Price 24-Hour Time-Series Raw Data
Daiichi Sankyo stock fell XXX% due to an unchanged profit target and pricing/market access challenges, despite positive oncology pipeline news. Social posts also mention potential tariffs impacting Japanese-made drugs, which could further influence market sentiment.

1-Year High: $XXXXX on 2025-01-22
1-Year Low: $XXXXX on 2025-04-17

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Daiichi Sankyo Company Limited is currently AltRank #890 based on combined combined social and market metrics Daily Average: XXX
1-Year High: XXXXX on 2025-03-10
1-Year Low: XXX on 2025-01-21

Galaxy Score: XX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-25
1-Year Low: XX on 2025-07-21

Engagements: XXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX -XX%
1-Year High: XXXXXXXXX on 2025-03-31
1-Year Low: XX on 2025-01-09

Engagements by network (24h): Reddit: XX TikTok: X X: XXX YouTube: XX

Mentions: XX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX no change
X Month: XXX -XX%
X Months: XXX -XXXX%
X Year: XXXXX +109%
1-Year High: XX on 2025-07-18
1-Year Low: X on 2024-12-16

Mentions by network (24h): Reddit: XX TikTok: X X: XX YouTube: X

Creators: XX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XXXX%
X Month: XX -XX%
X Months: XXX -XXXX%
X Year: XXX +117%
1-Year High: XX on 2025-07-04
1-Year Low: X on 2024-12-16

The most influential creators that mention Daiichi Sankyo Company Limited in the last XX hours

Creator Rank Followers Posts Engagements
@ABNewswire X XXXXX X XX
@H2AK119ub X XXXXXX X XX
@newjerseyheadli X XXX X XX
@DaiichiSankyoUS X XXXXX X XX
@tom_the_bomb__ X XXXXX X XX
@daiichisankyoeurope X XXX X X
@biotechtv X XXXXX X X

View More

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XXX% +50%
X Month: XXX% no change
X Months: XXX% +27%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-02-01

Most Supportive Themes:

Most Critical Themes:

Market Cap: $undefined

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXX on 2025-01-22
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-20

Top Daiichi Sankyo Company Limited Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Ovarian Cancer Pipeline 2025: Key Companies MOA ROA and Clinical Trials Evaluation by DelveInsight Pfizer Daiichi Sankyo Astellas Pharma Jiangsu HengRui Boehringer Ingelheim #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
X Link @ABNewswire 2025-12-11T15:56Z 1656 followers, XX engagements

"Ovarian Cancer Pipeline 2025: Key Companies MOA ROA and Clinical Trials Evaluation by DelveInsight Pfizer Daiichi Sankyo Astellas Pharma Jiangsu HengRui Boehringer Ingelheim Impact Therap"
X Link @newjerseyheadli 2025-12-11T14:33Z XXX followers, XX engagements

"HER2+ Gastric Cancer Market Revenue to Expand Significantly by 2034 States DelveInsight Report Pfizer Bayer Merck Daiichi Sankyo and AstraZeneca Jazz Pharma BeiGene Zymeworks #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
X Link @ABNewswire 2025-12-10T17:26Z 1656 followers, XX engagements

"HER2+ Gastric Cancer Market Revenue to Expand Significantly by 2034 States DelveInsight Report Pfizer Bayer Merck Daiichi Sankyo and AstraZeneca Jazz Pharma BeiGene Zymeworks ALX Oncology"
X Link @newjerseyheadli 2025-12-10T16:21Z XXX followers, XX engagements